Milgamma (Benfotiamine, Cyanocobalamin)

Milgamma is used to address conditions related to vitamin B1 and B12 deficiencies and associated neuropathies.

• Peripheral neuropathy: helps alleviate nerve‑related symptoms such as tingling and pain.
• Diabetic neuropathy: supports nerve health in patients with diabetes‑related nerve damage.
• Vitamin B1 deficiency: restores thiamine levels essential for carbohydrate metabolism.
• Vitamin B12 deficiency: contributes to normal red blood cell formation and neurologic function.

• Benfotiamine, a lipid‑soluble thiamine pro‑drug, is converted intracellularly to thiamine pyrophosphate, enhancing carbohydrate metabolism and nerve function. Cyanocobalamin supplies vitamin B12, which acts as a co‑factor in DNA synthesis, erythropoiesis and myelin formation, thereby supporting hematologic and neurologic health.

Milgamma may cause adverse reactions, most of which are mild and reversible.

Common Side Effects

• Gastrointestinal discomfort: nausea, abdominal cramps or mild diarrhea.
• Skin reactions: mild rash or itching at the site of contact.
• Headache: transient mild headache.
• Metallic taste: occasional altered taste perception.

Serious or Rare Side Effects

• Allergic reaction: hives, swelling, or difficulty breathing.
• Severe skin eruption: Stevens‑Johnson syndrome or toxic epidermal necrolysis.
• Hematologic changes: unexplained anemia or leukopenia.
• Neurological symptoms: new or worsening neuropathic pain.

Before using Milgamma, consider the following safety measures.

• Pregnancy: consult a healthcare professional before use, as safety data are limited.
• Breastfeeding: discuss potential risks with a physician.
• Renal impairment: monitor renal function and adjust use if necessary.
• Drug interactions: review concomitant medications for possible interactions.
• Storage: Store below 25°C: keep in the original container, protect from moisture and direct sunlight.

Milgamma can interact with certain medications; awareness of these interactions helps ensure safe use.

Major Interactions (Avoid)

• Metformin: may reduce thiamine absorption, potentially diminishing therapeutic effect.
• Proton pump inhibitors: can impair cyanocobalamin absorption, leading to reduced B12 availability.

Moderate Interactions (Monitor Closely)

• Anticonvulsants (e.g., phenytoin): may increase vitamin B12 metabolism, requiring monitoring.
• Diuretics: can affect electrolyte balance, necessitating periodic assessment.
• Antibiotics (e.g., tetracycline): may interfere with vitamin absorption, warranting observation.